Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha
K. Crawford and P. L. Kaufman
Twice daily topical application of 50 micrograms of prostaglandin F2 alpha
tromethamine to cynomolgus monkey eyes produced significant ocular
hypotension lasting at least six hours, with the intraocular pressure (IOP)
falling between 35% and 50%, ie, to about 8 to 10 mm Hg, following the
seventh dose. A single topical application of 1 mg of pilocarpine
hydrochloride produced a much smaller IOP reduction and strong, probably
maximal accommodation, both of which lasted at least eight hours. When
prostaglandin F2 alpha-treated eyes were given pilocarpine before the
seventh dose of prostaglandin F2 alpha, accommodation and IOP responded as
in eyes receiving pilocarpine only. Atropine sulfate pretreatment of eyes
receiving pilocarpine and prostaglandin F2 alpha completely prevented
pilocarpine-induced accommodation and inhibition of ocular hypotension
induced by prostaglandin F2 alpha. We hypothesize that (1) prostaglandin F2
alpha reduces IOP by increasing uveoscleral drainage of aqueous humor, and
(2) pilocarpine pretreatment contracts the ciliary muscle, obliterating the
intramuscular spaces and closing off the uveoscleral drainage pathway and
thus physiologically blocking the effect.
The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review
Hodge et al.
Br. J. Ophthalmol. 2008;92:7-12.
ABSTRACT
| FULL TEXT
Acute Effects of PGF2{alpha} on MMP-2 Secretion from Human Ciliary Muscle Cells: A PKC- and ERK-Dependent Process
Husain et al.
IOVS 2005;46:1706-1713.
ABSTRACT
| FULL TEXT
Aqueous Humor Dynamics in Monkeys after Topical 8-Iso PGE2
Gabelt et al.
IOVS 2004;45:892-899.
ABSTRACT
| FULL TEXT
Morphological Changes in the Anterior Eye Segment after Long-Term Treatment with Different Receptor Selective Prostaglandin Agonists and a Prostamide
Richter et al.
IOVS 2003;44:4419-4426.
ABSTRACT
| FULL TEXT
An Aldose Reductase with 20alpha -Hydroxysteroid Dehydrogenase Activity Is Most Likely the Enzyme Responsible for the Production of Prostaglandin F2alpha in the Bovine Endometrium
Madore et al.
J. Biol. Chem. 2003;278:11205-11212.
ABSTRACT
| FULL TEXT
Alterations in Arachidonic Acid Release and Phospholipase C-{beta}1 Expression in Glaucomatous Human Ciliary Muscle Cells
Husain et al.
IOVS 2002;43:1127-1134.
ABSTRACT
| FULL TEXT
From PGF2{{alpha}}-Isopropyl Ester to Latanoprost: A Review of the Development of Xalatan The Proctor Lecture
Stjernschantz
IOVS 2001;42:1134-1145.
FULL TEXT
Responses of Intraocular Pressure and the Pupil of Feline Eyes to Prostaglandin EP1 and FP Receptor Agonists
Bhattacherjee et al.
IOVS 1999;40:3047-3053.
ABSTRACT
| FULL TEXT
Flow after Prostaglandin E1 Is Mediated by Receptor-Coupled Adenylyl Cyclase in Human Anterior Segments
Dijkstra et al.
IOVS 1999;40:2622-2626.
ABSTRACT
| FULL TEXT
Medical Management of Glaucoma
Alward
NEJM 1998;339:1298-1307.
FULL TEXT
Functional Characterization of the Ocular Prostaglandin F2alpha (PGF2alpha ) Receptor. ACTIVATION BY THE ISOPROSTANE, 12-iso-PGF2alpha
Kunapuli et al.
J. Biol. Chem. 1997;272:27147-27154.
ABSTRACT
| FULL TEXT
Effects on IOP restoration and blood-aqueous barrier after long term treatment with latanoprost in open angle glaucoma and ocular hypertension
Linden et al.
Br. J. Ophthalmol. 1997;81:370-372.
ABSTRACT
| FULL TEXT